You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

GENTAMICIN SULFATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for gentamicin sulfate and what is the scope of patent protection?

Gentamicin sulfate is the generic ingredient in twelve branded drugs marketed by Schering, Pharmafair, Alpharma Us Pharms, Cosette, Fougera Pharms Inc, Padagis Us, Pharmaderm, Taro, King Pharms, Bristol, Intl Medication, Abbott, Eugia Pharma, Fresenius Kabi Usa, Hikma, Hospira, Kalapharm, Pharm Spec, Solopak, Teva Parenteral, Watson Labs, Wyeth Ayerst, B Braun, Baxter Hlthcare, Pharmacia And Upjohn, Novartis, Fera Pharms Llc, Sciegen Pharms Inc, Encube, Allergan, Alcon Pharms Ltd, Bausch And Lomb, Epic Pharma Llc, Paco, and Sandoz, and is included in sixty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for gentamicin sulfate. Twenty-seven suppliers are listed for this compound.

Summary for GENTAMICIN SULFATE
US Patents:0
Tradenames:12
Applicants:35
NDAs:62
Drug Master File Entries: 14
Finished Product Suppliers / Packagers: 27
Raw Ingredient (Bulk) Api Vendors: 87
Clinical Trials: 13
Patent Applications: 626
What excipients (inactive ingredients) are in GENTAMICIN SULFATE?GENTAMICIN SULFATE excipients list
DailyMed Link:GENTAMICIN SULFATE at DailyMed
Drug Sales Revenue Trends for GENTAMICIN SULFATE

See drug sales revenues for GENTAMICIN SULFATE

Recent Clinical Trials for GENTAMICIN SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Oslo University HospitalPhase 1/Phase 2
University of California, San DiegoPhase 2
Kaiser PermanentePhase 2

See all GENTAMICIN SULFATE clinical trials

Pharmacology for GENTAMICIN SULFATE

US Patents and Regulatory Information for GENTAMICIN SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms APOGEN gentamicin sulfate INJECTABLE;INJECTION 062289-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER gentamicin sulfate INJECTABLE;INJECTION 062414-002 Aug 15, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Solopak GENTAMICIN SULFATE gentamicin sulfate INJECTABLE;INJECTION 062507-002 Jun 6, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER gentamicin sulfate INJECTABLE;INJECTION 062414-009 Aug 15, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Solopak GENTAMICIN SULFATE gentamicin sulfate INJECTABLE;INJECTION 062507-001 Jun 6, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
B Braun GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER gentamicin sulfate INJECTABLE;INJECTION 062814-005 Aug 28, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.